News | July 30, 2014

Hidden Information Behind Imaging Tests for Cancer May Unlock New Approaches to Radiation Therapy

Emerging field of radiomics can provide insights into cancer treatment success

Radiomics uses computer algorithms to pull out data from imaging to use in automated diagnosis and risk stratification, which otherwise is not evident to the human eye.Dave Fornell

July 30, 2014 — Information hidden in imaging tests could help doctors more accurately choose the radiation therapy dose needed to kill tumors, suggests a study of more than 300 cancer patients presented at the 56th Annual Meeting of the American Association of Physicists in Medicine (AAPM).

The research is the largest study to date to use radiomics — extracting statistical information from images and other measurements — to help predict the likely progression of cancer or its response to treatment based on positron emission tomography (PET) scans of patients with non-small-cell lung cancer and head and neck cancer.

“Currently, there is a one-size-fits-all process for selecting radiation therapy doses, which might be too much for some patients and not enough for others,” said Joseph Deasy, Ph.D., senior author of the study and chair of the department of medical physics at Memorial Sloan-Kettering Cancer Center, New York. “Radiomics will help us know when we can turn down the treatment intensity with confidence, knowing we can still control the disease.”

In the study, researchers performed positron emission tomography (PET) scans in 163 non-small cell lung cancer patients and 174 head and neck cancer patients before and after treatment. They extracted a variety of information from each tumor, including the intensity value of the PET image, the roughness of the image and other information, such as how round the tumor was. In PET, the brighter an area is, the higher the intensity, showing that the tumor is consuming a greater amount of energy from the injected radioactive glucose substitute tracer.

Comparing the information gleaned from the before and after scans to how the patient fared — including whether the tumor shrank or how long the patient survived — researchers can create models that will help direct future therapy. For example, in the study researchers determined that lung tumors that have a higher uptake of the tracer need to be treated with a higher dose of radiation than is typically prescribed.

“Standard protocol today is to only use PET imaging to define the extent of a tumor to be treated,” said Deasy. “Based on the information from this study, the data would be extracted from those images and put into models that would tell the physician what dose was required to kill the tumor with a high probability.”

He noted that radiomics is a team effort that requires good collaboration between physicians, physicists and computer scientists.

In addition to Deasy, collaborators on the study are: J. Oh, H. Veeraraghavan, A. Apte, A. Rimner, M. Folkert, N. Lee, Z. Kohutek, H. Schoeder, M. Dunphy, J. Humm and S. Nehmeh.

For more information: www.aapm.org

Related Content

News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...